Track APRE and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
APRE - Aprea Therapeutics Inc (APRE) has a earnings per share of -$0.22, up 66.5% over the past year.
Latest EPS (Actual)
-$0.22
Beat Rate
62.5%
Most Recent
Meet
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$0.23 | -$0.22 | Meet | +4.35% |
| Mar 2026 | -$0.36 | -$0.32 | Beat | +11.11% |
| Nov 2025 | -$0.34 | -$0.47 | Miss | -38.24% |
| Aug 2025 | -$0.71 | -$0.53 | Beat | +25.35% |
| May 2025 | -$1.00 | -$0.66 | Beat | +34.39% |
| Mar 2025 | -$0.54 | -$0.49 | Beat | +9.26% |
| Nov 2024 | -$0.74 | -$0.64 | Beat | +13.51% |
| Aug 2024 | -$0.60 | -$0.58 | Meet | +3.33% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.